STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3914 by analyst upside · 2026-06-27
MD
Pediatrix Medical Group, Inc.
Healthcare · Market Cap $2B · P/E 12.0x
ANALYST PRICE TARGET
-6.1%
implied upside to consensus target
Current Price $24.68
Consensus Target $23.17
Bull Target $27.0
Bear Target $19.0
Analysts Covering 6
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
2
Hold
4
Sell
0
52-Week Low $11.84
52-Week High $24.99
YTD Return +15.9%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 12.0x
Forward P/E 10.5x
EPS (TTM) $2.06
PEG Ratio 0.24
Dividend Yield N/A
Revenue (TTM) $1.9B
Profit Margin 9.0%
52-WEEK RANGE
52-Week Low $11.84
52-Week High $24.99
Current Price $24.68
Bear Target $19.0
Bull Target $27.0
● Now $24.68 ● Target $23.17
TRADING DATA
Avg Volume 786K
YTD Return +15.9%
Analyst Count 6
Consensus Hold
Upside to Target -6.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Pediatrix Medical Group, Inc. (MD) is currently trading at $24.68 with a Wall Street consensus price target of $23.17, which is 6.1% below the current price over the next 12 months. 6 analysts currently cover MD, with a consensus rating of Hold — 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $27.0, while the most cautious has a target of $19.0.

MD operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 15.9% year-to-date and is currently trading near the upper end of its 52-week range of $11.84 – $24.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS — Reiterated
Neutral → Neutral 2026-05-12 33% win rate (6 calls)
Truist Securities — Reiterated
Hold → Hold 2026-04-13 Building track record
UBS — Reiterated
Neutral → Neutral 2026-02-24 33% win rate (6 calls)
Truist Securities — Reiterated
Hold → Hold 2026-02-20 Building track record
Truist Securities — Reiterated
Hold → Hold 2025-11-10 Building track record
UBS — Reiterated
Neutral → Neutral 2025-11-05 33% win rate (6 calls)
Leerink Partners — Reiterated
Market Perform → Market Perform 2025-09-05 29% win rate (7 calls)
UBS — Reiterated
Neutral → Neutral 2025-08-14 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →